Dicofol degradation to p,p'-dichlorobenzophenone - A potential antiandrogenTHIEL, Anette; GUTH, Sabine; BÖHM, Sonja et al.Toxicology (Amsterdam). 2011, Vol 282, Num 3, pp 88-93, issn 0300-483X, 6 p.Article

Sensitive in vitro test systems to determine androgenic/antiandrogenic activityGUTH, Sabine E; BÖHM, Sonja; MUSSLER, Bernd H et al.Molecular nutrition & food research (Print). 2004, Vol 48, Num 4, pp 282-291, issn 1613-4125, 10 p.Article

LES ANTI-ANDROGENES.SAVOU RET JF; MILGROM E.1978; GAZ. MED. FR.; FR.; DA. 1978; VOL. 85; NO 2; PP. 129-134 (5P.); ABS. ANGL.; BIBL. 12 REF.Article

Tolerance of spironolactoneHUGHES, B. R; CUNLIFFE, W. J.British journal of dermatology (1951). 1988, Vol 118, Num 5, pp 687-691, issn 0007-0963Article

Anti-androgens in treatment of acne vulgarisMOHAMED AMER; ALI RAMADAN; AHMED ABDEL MONEM et al.International journal of dermatology. 1985, Vol 24, Num 8, pp 533-534, issn 0011-9059Article

Androgen and antiandrogen receptor bindingJANNE, O. A; BARDIN, C. W.Annual review of physiology. 1984, Vol 46, pp 107-118, issn 0066-4278Article

DIE KLINISCHE ANWENDUNG VON ANTIANDROGENEN IN DER PSYCHIATRIE = L'UTILISATION CLINIQUE DES ANTIANDROGENES EN PSYCHIATRIEHOFFET H.1980; GYNAEKOLOGIE; DEU; DA. 1980; VOL. 13; NO 1; PP. 33-43; BIBL. 2 P.Article

PARTICIPATION DE L'HYPOTHALAMUS AUX REPONSES PITUITAIRE ET TESTICULAIRE DE RATS A L'ADMINISTRATION DE L'ANTIANDROGENE 4-NITRO-3-TRIFLUOROMETHYLISOBUTYRANILIDEREZNIKOV AG; VOLKOVA NN.1979; BJULL. EKSPER. BIOL. MED.; SUN; DA. 1979; VOL. 88; NO 11; PP. 601-603; ABS. ENG; BIBL. 8 REF.Article

Antiandrogen and antineoplastic effects of a novel drug, CPC 10997FORD, L. C; KASHA, W; CHANG, N. H. C et al.Chemotherapy (Basel). 1985, Vol 31, Num 5, pp 362-365, issn 0009-3157Article

Long-term treatment with antiandrogensRASMUSSEN, F.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 917-919, issn 0960-0760, 3 p.Conference Paper

ANTIANDROGENIC EFFECT OF CIMETIDINE IN MICEBROULIK PO.1980; ENDOKRINOLOGIE; ISSN 0013-7251; DDR; DA. 1980; VOL. 76; NO 1; PP. 118-121; BIBL. 16 REF.Article

Flutamine as primary treatment for metastatic prostatic cancerLUNDGREN, R.British journal of urology (Print). 1987, Vol 59, Num 2, pp 156-158, issn 0007-1331Article

Traitement de l'hirsutisme idiopathique par la spironolactone = Treatment of idiopathic hirsutism by spironolactoneSCHLIENGER, J. L; SAPIN, R.Revue française d'endocrinologie clinique, nutrition et métabolisme. 1985, Vol 26, Num 3, pp 257-260, issn 0048-8062Article

A randomized-double-blind study evaluating anandron® associated with orchiectomy in stage D prostate cancerNAMER, M; TOUBOL, J; CATY, A et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 909-915, issn 0960-0760, 7 p.Conference Paper

Treating acne with antiandrogens: the confirmation of the validity of a percutaneous treatment with spironolactoneMESSINA, M; MANIERI, C; RIZZI, G et al.Current therapeutic research. 1985, Vol 38, Num 2, pp 269-282, issn 0011-393XArticle

ANTI-ANDROGENS IN HIRSUTISMEBLING FJ.1979; INTERNATION. J. DERMATOL.; USA; DA. 1979; VOL. 18; NO 1; PP. 39-41; BIBL. 7 REF.Article

DANAZOL INHIBITS STEROIDOGENESIS IN THE RAT TESTIS IN VITRO.BARBIERI RL; CANICK JA; RYAN RJ et al.1977; ENDOCRINOLOGY; U.S.A.; DA. 1977; VOL. 101; NO 6; PP. 1676-1682; BIBL. 22 REF.Article

Effect of organochlorine pesticides on human androgen receptor activation in vitroLEMAIRE, Géraldine; TEROUANNE, Béatrice; MAUVAIS, Pascale et al.Toxicology and applied pharmacology. 2004, Vol 196, Num 2, pp 235-246, issn 0041-008X, 12 p.Article

COMMON BALDNESS IN WOMENDAWBER RPR.1981; INT. J. DERMATOL.; ISSN 0011-9059; USA; DA. 1981; VOL. 20; NO 10; PP. 647-650; BIBL. 40 REF.Article

PROBLEMI DIAGNOSTICI E PROSPETTIVE TERAPEUTICHE DELL' IRSUTISMO = DIAGNOSTIC ET TRAITEMENT DE L'HIRSUTISMEMESSALLI E; CANDIDO R; MERLINO G et al.1978; ARCH. OSTETR. GINECOL.; ITA; DA. 1978; VOL. 83; NO 5-6; PP. 197-211; ABS. ENG; BIBL. 20 REF.Article

Indikation und Grenzen der antiandrogenen Therapie = Indication et limites du traitement antiandrogène = Indications and limits of treatment with antiandrogensZAUN, H.H + G. Zeitschrift für Hautkrankheiten. 1984, Vol 59, Num 16, pp 1090-1097, issn 0301-0481Article

RELEASE OF MICROQUANTITIES OF CYPROTERONE ACETATE FROM SUBCUTANEOUS SILASTIC CAPSULES: FAILURE TO PRODUCE AN ANTIFERTILITY EFFECT.BACK DJ; SHENTON JC.1976; CONTRACEPTION; U.S.A.; DA. 1976; VOL. 14; NO 1; PP. 17-24; BIBL. 5 REF.Article

Cumulative effects of in utero administration of mixtures of reproductive toxicants that disrupt common target tissues via diverse mechanisms of toxicity. DiscussionRIDER, C. V; FURR, J. R; WILSON, V. S et al.International journal of andrology (Print). 2010, Vol 33, Num 2, pp 443-462, issn 0105-6263, 20 p.Conference Paper

Biological profile of cortexolone 17α-propionate (CB-03-01), a new topical and peripherally selective androgen antagonistCELASCO, Giuseppe; MORO, Luigi; BOZZELLA, Roberta et al.Arzneimittel-Forschung. 2004, Vol 54, Num 12, pp 881-886, issn 0004-4172, 6 p.Article

A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activityCHARLES, Grantley D; KAN, H. Lynn; SCHISLER, Melissa R et al.Toxicology and applied pharmacology. 2005, Vol 202, Num 1, pp 108-120, issn 0041-008X, 13 p.Article